LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases

作者:Xia, Fangqi; Wang, Yaqi; Xue, Mengzhen; Zhu, Leiqi; Jia, Dengke; Shi, Yue; Gao, Yan; Li, Luoying; Li, Yuanyang; Chen, Silong; Xu, Guangfu; Yuan, Ding*; Yuan, Chengfu*
来源:Genes & Diseases, 2022, 9(6): 1556-1565.
DOI:10.1016/j.gendis.2021.07.003

摘要

Long non-coding RNAs (lncRNAs) exhibit a length more than 200 nucleotides and they are characterized by non-coding RNAs (ncRNA) not encoded into proteins. Over the past few years, the role and development of lncRNAs have aroused the rising attention of re-searchers. To be specific, KCNQ1OT1, the KCNQ1 opposite strand/antisense transcript 1, is clearly classified as a regulatory ncRNA. KCNQ1OT1 is capable of interacting with miRNAs, RNAs and proteins, thereby affecting gene expression and various cell functions (e.g., cell prolifer-ation, migration, epithelial-mesenchymal transition (EMT), apoptosis, viability, autophagy and inflammation). KCNQ1OT1 is dysregulated in a wide range of human diseases (e.g., cardio-vascular disease, cancer, diabetes, osteoarthritis, osteoporosis and cataract), and it is specu-lated to act as a therapeutic target for treating various human diseases. On the whole, this review aims to explore the biological functions, underlying mechanisms and pathogenic roles of KCNQ1OT1 in human diseases.Copy

  • 单位
    中国医科大学